These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17147813)

  • 1. Improving the use of research evidence in guideline development: 11. Incorporating considerations of cost-effectiveness, affordability and resource implications.
    Edejer TT
    Health Res Policy Syst; 2006 Dec; 4():23. PubMed ID: 17147813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating considerations of cost-effectiveness, affordability, and resource implications in guideline development: article 6 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Hill SR; Olson LG; Falck-Ytter Y; Cruz AA; Atkins D; Baumann M; Jaeschke R; Woitalla T; Schünemann HJ;
    Proc Am Thorac Soc; 2012 Dec; 9(5):251-5. PubMed ID: 23256167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the use of research evidence in guideline development: 2. Priority setting.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Nov; 4():14. PubMed ID: 17134481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the use of research evidence in guideline development: 16. Evaluation.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():28. PubMed ID: 17156460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving the use of research evidence in guideline development: 3. Group composition and consultation process.
    Fretheim A; Schünemann HJ; Oxman AD
    Health Res Policy Syst; 2006 Nov; 4():15. PubMed ID: 17134482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving the use of research evidence in guideline development: 14. Reporting guidelines.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():26. PubMed ID: 17156458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the use of research evidence in guideline development: 7. Deciding what evidence to include.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():19. PubMed ID: 17140445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement.
    Schünemann HJ; Fretheim A; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():22. PubMed ID: 17147811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():24. PubMed ID: 17147814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the use of research evidence in guideline development: 8. Synthesis and presentation of evidence.
    Oxman AD; Schünemann HJ; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():20. PubMed ID: 17147809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving from evidence to developing recommendations in guidelines: article 11 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report.
    Schünemann HJ; Oxman AD; Akl EA; Brozek JL; Montori VM; Heffner J; Hill S; Woodhead M; Campos-Outcalt D; Alderson P; Woitalla T; Puhan MA; Falck-Ytter Y; Bousquet J; Guyatt G;
    Proc Am Thorac Soc; 2012 Dec; 9(5):282-92. PubMed ID: 23256172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines.
    Fretheim A; Schünemann HJ; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():27. PubMed ID: 17156459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the use of research evidence in guideline development: 5. Group processes.
    Fretheim A; Schünemann HJ; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():17. PubMed ID: 17140442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the use of research evidence in guideline development: 13. Applicability, transferability and adaptation.
    Schünemann HJ; Fretheim A; Oxman AD
    Health Res Policy Syst; 2006 Dec; 4():25. PubMed ID: 17156457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the use of research evidence in guideline development: 1. Guidelines for guidelines.
    Schünemann HJ; Fretheim A; Oxman AD;
    Health Res Policy Syst; 2006 Nov; 4():13. PubMed ID: 17118181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the use of research evidence in guideline development: 6. Determining which outcomes are important.
    Schünemann HJ; Oxman AD; Fretheim A
    Health Res Policy Syst; 2006 Dec; 4():18. PubMed ID: 17140444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to develop cost-conscious guidelines.
    Eccles M; Mason J
    Health Technol Assess; 2001; 5(16):1-69. PubMed ID: 11427188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based clinical guidelines in Kyrgyz Republic.
    Zurdinova AA
    Int J Risk Saf Med; 2015; 27 Suppl 1():S45-6. PubMed ID: 26639705
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.